Using siRNA-mediated knockdown of PRDM3 in PK-8 pancreatic cancer cells, Tanaka and colleagues also showed that PRDM3 promotes pancreatic cancer cell proliferation and migration through the inhibition of a KRAS suppressor miR-9614. Here, MECOM is linked to familial pancreatic carcinoma.